Annual Meeting Materials

Consolidated Financial Statements for the six month period ending February 29, 2020 (Q2)

MD&A for the six month period ending February 29, 2020 (Q2)

Notice of Annual General Meeting

Management Information Circular

Proxy

Supplemental Mail Card

Voter Information Form

Algernon Pharmaceuticals is a clinical stage pharmaceutical development company.

Sign up for our News Releases and Updates

Head Office

Suite 400 - 601 West Broadway
Vancouver, British Columbia V5Z 4C2

Follow Us On

© Algernon Pharmaceuticals - All Rights Reserved